Recombinant antibodies for cancer therapy : methods and protocols /

Saved in:
Bibliographic Details
Imprint:Totowa, N.J. : Humana Press, c2003.
Description:xiv, 481 p. : ill. ; 24 cm.
Language:English
Series:Methods in molecular biology ; v. 207
Methods in molecular biology (Clifton, N.J.) ; v. 207.
Subject:
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/4756221
Hidden Bibliographic Details
Other authors / contributors:Welschof, Martin.
Krauss, Jürgen.
ISBN:0896039188 (alk. paper)
Notes:Includes bibliographical references and index.
Table of Contents:
  • Preface
  • Contributors
  • Part I.. Introduction
  • 1. Generation of Antibody Molecules Through Antibody Engineering
  • 2. Application of Recombinant Antibodies in Cancer Patients
  • Part II.. Hybridoma-Derived Antibodies
  • 3. DNA Immunization as a Means to Generate Antibodies to Proteins
  • 4. Chimerization of a Monoclonal Antibody for Treating Hodgkin's Lymphoma
  • 5. Humanization of Monoclonal Antibodies by CDR Grafting
  • Part III.. Recombinant Antibody Fragments from Phagemid-Displayed Antibody Repertoires
  • 6. Generation and Screening of a Modular Human scFv Expression Library from Mulitple Donors
  • 7. Construction of Semisynthetic Antibody Libraries
  • 8. Single-Domain V[subscript H] Antibody Fragments from a Phage Display Library
  • 9. Isolation of Human Fab Fragments Against Ovarian Carcinoma Using Guided Selection
  • 10. Human Recombinant Fab Antibodies with T-Cell Receptor-Like Specificities Generated from Phage Display Libraries
  • 11. Engineering Hot Spots for Affinity Enhancement of Antibodies
  • 12. Simultaneous Humanization and Affinity Optimization of Monoclonal Antibodies
  • 13. Tailoring Kinetics of Antibodies Using Focused Combinatorial Libraries
  • Part IV.. Antibody Fragments with Additional Properties
  • 14. Engineering scFvs for Improved Stability
  • 15. Recombinant Single-Chain and Disulfide-Stabilized Fv Immunotoxins for Cancer Therapy
  • 16. Generation of Recombinant Immunotoxins for Specific Targeting of Tumor-Related Peptides Presented by MHC Molecules
  • 17. Construction and Characterization of RNase-Based Targeted Therapeutics
  • 18. Bispecific Diabodies for Cancer Therapy
  • 19. Generation and Characterization of Bispecific Tandem Diabodies for Tumor Therapy
  • 20. Generation of Recombinant Multimeric Antibody Fragments for Tumor Diagnosis and Therapy
  • 21. Construction and Characterization of Minibodies for Imaging and Therapy of Colorectal Carcinomas
  • 22. Generation, Expression, and Monitoring of Recombinant Immune Receptors for Use in Cellular Immunotherapy
  • 23. Tailoring Natural Effector Functions: Antibody Engineering Beyond Humanization
  • 24. Single-Chain Fv-Based Affinity Purification of the Cellular Stress Protein gp96 for Vaccine Development
  • 25. Recombinant Adenoviruses for In Vivo Expression of Antibody Fragments
  • Part V.. Large Scale Production of Recombinant Antibodies for Clinical Application
  • 26. Production of Antibody Fragments in a Bioreactor
  • 27. Large Scale Production of Recombinant Antibodies by Utilizing Cellulose-Binding Domains
  • 28. Production of Tumor-Specific Antibodies in Tobacco
  • Index